Phase I dose escalation of MSC-1, a humanized anti-LIF monoclonal antibody, in patients (pts) with advanced solid tumours: Updated results Meeting Abstract
| Authors: | Borazanci, E.; Schram, A.; Brana, I.; Vieito Villar, M.; Garralda, E.; Spreafico, A.; Oliva, M.; Lakhani, N.; Wasserman, R.; Hoffman, K.; Hallett, R.; Anido, J.; Giblin, P.; Pandya, N.; Kelly, A.; Seoane, J.; Von Hoff, D. D.; Siu, L. L.; Hyman, D. M.; Tabernero, J. |
| Abstract Title: | Phase I dose escalation of MSC-1, a humanized anti-LIF monoclonal antibody, in patients (pts) with advanced solid tumours: Updated results |
| Meeting Title: | 44th ESMO Congress (ESMO 2019) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2019 Sep 27-Oct 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | mdz253.022 |
| Language: | English |
| ACCESSION: | WOS:000491295503244 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz253.022 |
| Notes: | Meeting Abstract: 1196P -- Appears on pages v487-v488 of the abstract book -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
